Editorial, Volume: 9( 2) DOI: 10.37532/2320-6756.2021.9(2).206
4th International Conference on Digestive and Metabolic Diseases, august 19-20, 2021 Simngapore, Singapore Theraputics for Digestive Diseases Cure
- Amora Evans
Managing Editor, Journal of Physics and Astronomy, United Kingdom
Received: February 02 ,2021; Accepted: February 16 ,2021; Published: February 24 ,2021
Citation:Amora Evans, 4th International Conference on Digestive and Metabolic Diseases, August 19-20, 2021 Singapore, Singapore Theraputics for Digestive Diseases Cure. J Phys Astron. 2021; 9(2):206
Digestive Disease 2021 conference theme is “To Explore the research in Gastroenterology Medicine and Liver Disease” which aims to provide a platform for science researchers, Scientists, Surgeons, Doctors, physician, and academicians to exchange and share their experiences and research results about all aspects of Digestive and Metabolic Disease. Digestive Disease 2021 will boost the advanced techniques and various methods for better healthcare management. This conference will provide best platform for the researchers and business leaders to acknowledge recent breakthroughs and invest in the field of Gastroenterology and for a better future.Conference Highlights
• Gastroenterology and Hepatology Faculties
• Directors of Gastroenterology and Hepatology
• Universities Gastro and Hepatology Students
• Pharmaceutical Industry Mentors and Marketers
• Gastro and Hepatology Scientists
• Directors of Medical universities
• Gastrologist and Hepatology research
• Exhibitors and Sponsors
Digestive Disease conference covers subject relating and to reducing any health problem that occurs in the digestive tract. Conditions may range from mild to serious Intestinal problems, such as polyps and cancer, infections, celiac disease, Crohn disease, ulcerative colitis, diverticulitis, malabsorption, short bowel syndrome, and intestinal ischemia these are the some of the streams covered in the conference.
Economic and business
Digestive Diseases Market is expected to grow from USD 17.27 billion in 2016 and reach USD 19.79 billion in 2022, growing at a CAGR of 2.3% during the forecast period. Our industry experts anticipate that within the Digestive diseases market, the GIT Anti-inflammatory drug will grow at the fastest CAGR ranging from 1% to 0.5%, during the forecast period. Based on the geographic regions, our experts anticipate that Europe will be the fastest-growing segment during the forecast period. The Europe region will grow at a CAGR ranking from 1% to 0.3% by 2022.
The field of Digestive Disease and Gastroenterology have not only helped the development in different fields in science and technology but also contributed towards the improvement of the quality of human life. The core aim of Digestive Disease 2021 Conference is to provide an opportunity for the delegates to meet, interact and exchange innovative ideas in the various areas of Digestive and Metabolic Disease.